Beverly L. Davidson, Ph.D.

faculty photo
Professor of Pathology and Laboratory Medicine
Arthur V. Meigs Chair in Pediatrics, Children's Hospital of Philadelphia
Director, Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia
Chief Scientific Strategy Officer (CSS), Children's Hospital of Philadelphia Research Institute
Department: Pathology and Laboratory Medicine
Graduate Group Affiliations

Contact information
The Children's Hospital of Philadelphia
3501 Civic Center Boulevard, 5060 CTRB
Philadelphia, PA 19104
Office: 267-426-0929
Fax: 215-590-3660
Education:
B.S. (Biology Major/Chemistry Minor; High Distinction)
Nebraska Wesleyan University, 1981.
Ph.D. (Biological Chemistry)
University of Michigan, 1987.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Research Expertise

Keywords:
Neurodegenerative Disease
RNA biology
Gene therapy
Animal models
Human treatment

Our lab is focused on genetic diseases that affect the brain. We study the mechanisms by which mutant gene products contribute to disease, and why certain brain regions are more susceptible. The team employs advanced molecular methods, sequencing and imaging modalities in animal models. The lab is also engaged in the development of next generation therapeutics for inherited disorders, including the engineering of novel gene therapy vector capsids and cargo to approach tissue and cell type specific treatments.

Selected Publications

Yrigollen CM, Simpson B, Lim E, Chen YH, Davidson B: The molecular and behavioral phenotypes altered in CGG knock-in mice edited using CRISPR. Presented at the 25th annual meeting of the American Society for Gene and Cell Therapy, Washington, DC Page: Poster M-160, May 2022.

Arora S, Vu A, Kulhankova K, Weaver M, Excoffon K, Liu X, vanderLoo JC, McCray PB, Davidson BL: Development of a stable cell line and downstream process for improved titer of GP64-pseudotyped lentivurus particle. Presented at the 25th annual meeting of the American Society for Gene and Cell Therapy, Washington, DC Page: Poster W-268, May 2022.

Leib DE, Chen YH, Ranum PT, Davidson BL: Peptide-modified AAVs targeting brain endothelial cells following intracerebroventricular or systemic administration in mice. Presented at the 25th annual meeting of the American Society for Gene and Cell Therapy, Washington, DC Page: Poster W-268, May 2022.

Simpson BP, Yrigollen CM, Ranum PT, Davidson BL: Long read nanopore sequencing reveals outcomes of AAV-CRISPR editing in the brain of transgenic mouse models. Presented at the 25th annual meeting of the American Society for Gene and Cell Therapy Page: Oral presentation, May 2022.

St-cyr S, Smith AR, Davidson BL: Temporal phenotypic changes in HD models for preclinical studies. Presented at the 25th annual meeting of the American Society for Gene and Cell Therapy Page: Poster #M-148, May 2022.

Tecedor L, Chen YH, Ranum PT, Keiser MS, Leib D, Cheng C, Lysenko E, Davidson BL: Evolved AAV capsids for gene therapy of CLN2 disease. Presented at the 25th annual meeting of the American Society for Gene and Cell Therapy Page: Poster #M-147, May 2022.

Robbins AB, Carrell EM, Keiser MS, Davidson BL: Combined over expression of hATXN1L and mutant ATXN1 knockdown rescues motor phenotypes and disease-related gene expression changes in B05 mice. Presented at the 25th annual meeting of the American Society for Gene and Cell Therapy, Washington, DC Page: Poster M-109, May 2022.

Carrell EM, Carrell ST, Davidson BL: Disease-responsive therapy for the treatment of myotonic dystrophy. Presented at the 25th annual meeting of the American Society for Gene and Cell Therapy Page: Oral presentation, May 2022.

Fagan K, Keiser M, Davidson B: Gene editing strategies to treat spinocerebellar ataxia type 1. Presented at the 25th annual meeting of the Society for Cell and Gene Therapy, Washington DC Page: Poster M-140, May 2022.

Fang L, Liu Q, Monteys AM, Gonzalez-Alegre P, Davidson BL, Wang K.: DeepRepeat: direct quantification of short tandem repeats on signal data from nanopore sequencing. Genome Biol 23(1): 108, April 2022.

back to top
Last updated: 05/16/2022
The Trustees of the University of Pennsylvania